It's estimated that Restless Leg Syndrome (RLS) affects 7 - 10% of adults worldwide. Many people online claim Actipatch is the only thing that helps their RLS. While there aren't any clinical studies supporting this, it could be a huge market for Actipatch as a "wellness" product.
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links